fluorodeoxyglucose f18 has been researched along with memantine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berghold, A; Enzinger, C; Fazekas, F; Kolassa, H; Ofner, P; Pendl, B; Ropele, S; Schmidt, H; Schmidt, R; Windisch, M | 1 |
Hertel, A; Hofmann, E; Kiessling, B; Krasz, D; Nikisch, G; Wagner, T; Wiedemann, G | 1 |
Black, SE; Chow, TW; Fam, D; Graff-Guerrero, A; Houle, S; Masellis, M; Pollock, BG; Tang-Wai, DF; Verhoeff, NP; Wilson, AA | 1 |
Chen, K; Huang, Q; Li, C; Li, G; Li, X; Lin, Z; Reiman, EM; Wang, T; Xiao, S | 1 |
Dedeurwaerdere, S; Deleye, S; Staelens, S; Stroobants, S; Verhaeghe, J; wyffels, L | 1 |
Langlois, X; Schmidt, M; Staelens, S; Stroobants, S; Wyckhuys, T; Wyffels, L | 1 |
1 review(s) available for fluorodeoxyglucose f18 and memantine
Article | Year |
---|---|
Three-year follow-up of a patient with early-onset Alzheimer's disease with presenilin-2 N141I mutation - case report and review of the literature.
Topics: Age of Onset; Alzheimer Disease; Cholinesterase Inhibitors; Codon; Donepezil; Electrophysiology; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Indans; Male; Memantine; Middle Aged; Mutation, Missense; Neuropsychological Tests; Pedigree; Piperidines; Presenilin-2; Radiography; Radionuclide Imaging; Radiopharmaceuticals; tau Proteins; Time Factors; Treatment Outcome | 2008 |
2 trial(s) available for fluorodeoxyglucose f18 and memantine
Article | Year |
---|---|
Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine.
Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Biomarkers; Disease Progression; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memantine; Middle Aged; Pilot Projects; Placebos | 2008 |
Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Chi-Square Distribution; China; Cognition; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Humans; Male; Memantine; Middle Aged; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Predictive Value of Tests; Psychiatric Status Rating Scales; Radiopharmaceuticals; Severity of Illness Index; tau Proteins; Time Factors; Treatment Outcome | 2013 |
3 other study(ies) available for fluorodeoxyglucose f18 and memantine
Article | Year |
---|---|
Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot study.
Topics: Antiparkinson Agents; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Memantine; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2013 |
Towards a reproducible protocol for repetitive and semi-quantitative rat brain imaging with (18) F-FDG: exemplified in a memantine pharmacological challenge.
Topics: Animals; Brain; Computer Simulation; Fasting; Fluorodeoxyglucose F18; Image Enhancement; Male; Memantine; Metabolic Clearance Rate; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity | 2014 |
The [18F]FDG μPET readout of a brain activation model to evaluate the metabotropic glutamate receptor 2 positive allosteric modulator JNJ-42153605.
Topics: Allosteric Regulation; Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Cyclic S-Oxides; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Ketamine; Male; Memantine; Pyridines; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Triazines | 2014 |